ZA953701B - New atagonist compounds - Google Patents

New atagonist compounds

Info

Publication number
ZA953701B
ZA953701B ZA953701A ZA953701A ZA953701B ZA 953701 B ZA953701 B ZA 953701B ZA 953701 A ZA953701 A ZA 953701A ZA 953701 A ZA953701 A ZA 953701A ZA 953701 B ZA953701 B ZA 953701B
Authority
ZA
South Africa
Prior art keywords
pct
atagonist
compounds
new
sec
Prior art date
Application number
ZA953701A
Other languages
English (en)
Inventor
Helmut Schmidhammer
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA953701B publication Critical patent/ZA953701B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA953701A 1994-05-18 1995-05-08 New atagonist compounds ZA953701B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401728A SE9401728D0 (sv) 1994-05-18 1994-05-18 New compounds II

Publications (1)

Publication Number Publication Date
ZA953701B true ZA953701B (en) 1995-11-20

Family

ID=20394059

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953701A ZA953701B (en) 1994-05-18 1995-05-08 New atagonist compounds

Country Status (11)

Country Link
US (1) US6136817A (de)
EP (1) EP0759922B1 (de)
JP (1) JP4117801B2 (de)
AT (1) ATE259815T1 (de)
AU (1) AU690996B2 (de)
DE (1) DE69532580T2 (de)
ES (1) ES2214501T3 (de)
IL (1) IL113631A0 (de)
SE (1) SE9401728D0 (de)
WO (1) WO1995031463A1 (de)
ZA (1) ZA953701B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3123080B2 (ja) * 1995-09-26 2001-01-09 東レ株式会社 「インドール誘導体およびその医薬用途」
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
CA2269910A1 (en) * 1996-11-19 1998-05-28 Zhong-Yong Wei New process for the preparation of morphinans
ES2217533T3 (es) * 1997-01-16 2004-11-01 Toray Industries, Inc. Derivados de indolomorfinano y medicamentos/preventivos para transtornos cerebrales.
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
AU2003217436A1 (en) * 2002-02-15 2003-09-09 Howard Brooks-Korn Use of opioid compound to treat a neurologic or neurogenic disorder
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
ES2332453T3 (es) 2002-11-08 2010-02-05 Mallinckrodt Inc. Proceso para la preparacion de sales de n-alquilo cuaternario de alcaloides de morfinano.
EP1595541A1 (de) * 2004-05-12 2005-11-16 Alcasynn Pharmaceuticals Gmbh Verwendung von Opioid-Rezeptor Antagonisten zur Vorbeugung und/oder Behandlung von Krankheiten die im zusammenhang mit den Angrifftspunkt Calcineurin stehen
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006064779A1 (ja) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. ６’位にカルボキシを有するインドロモルヒナン誘導体
EP2012686B1 (de) * 2006-04-18 2013-10-02 Joseph Nicholas Logan Spinales stangensystem
RU2009112685A (ru) * 2006-09-20 2010-10-27 Маллинкродт Инк. (Us) Получение замещенных морфинан-6-онов и их солей и промежуточных соединений
US9040726B2 (en) * 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
US8669366B2 (en) * 2007-03-06 2014-03-11 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
CA2702680A1 (en) * 2007-10-18 2009-04-23 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
WO2009079013A1 (en) * 2007-12-17 2009-06-25 Mallinckrodt Inc. Processes for the production of (+)-'nal' morphinan compounds
WO2009132313A2 (en) * 2008-04-25 2009-10-29 Progenics Pharmaceuticals, Inc. Morphinan derivatives of organic and inorganic acids
WO2009146288A1 (en) * 2008-05-27 2009-12-03 Mallinckrodt Inc. Processes and compounds for the preparation of normorphinans
US9458109B2 (en) * 2008-09-03 2016-10-04 Mallinckrodt Llc Substituted berbines and processes for their synthesis
EP2340832A1 (de) 2009-12-23 2011-07-06 Universität Innsbruck Morphinan-6-one-Verbindungen zur Behandlung oder Prävention von neurodegenerativen Erkrankungen
CA2908805A1 (en) * 2013-03-08 2014-09-12 The Kitasato Institute Morphinan derivative
ES2784690T3 (es) 2013-12-05 2020-09-29 Univ Bath Nuevos compuestos opioides y sus usos
WO2020012248A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Novel naphthylenyl compounds for long-acting injectable compositions and related methods
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
WO2020094634A1 (en) 2018-11-05 2020-05-14 Alkermes Pharma Ireland Limited Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
JPH04342529A (ja) * 1991-05-21 1992-11-30 Toray Ind Inc 抗アレルギー剤
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds
US5223507A (en) * 1992-01-21 1993-06-29 G. D. Searle & Co. Method of using opioid compounds as delta opioid selective agonist analgesics
WO1994007896A1 (en) * 1992-09-29 1994-04-14 Toray Industries, Inc. Indole derivative, process for producing the same, and medicinal use thereof

Also Published As

Publication number Publication date
EP0759922A1 (de) 1997-03-05
US6136817A (en) 2000-10-24
EP0759922B1 (de) 2004-02-18
DE69532580T2 (de) 2004-07-29
JPH10500131A (ja) 1998-01-06
WO1995031463A1 (en) 1995-11-23
JP4117801B2 (ja) 2008-07-16
ES2214501T3 (es) 2004-09-16
AU2581795A (en) 1995-12-05
ATE259815T1 (de) 2004-03-15
SE9401728D0 (sv) 1994-05-18
DE69532580D1 (de) 2004-03-25
AU690996B2 (en) 1998-05-07
IL113631A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
ZA953701B (en) New atagonist compounds
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
AU649115B2 (en) New heterocycle-substituted alkylamides, process for preparing them and pharmaceutical compositions containing them
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
MX9603092A (es) Nuevos compuestos con efecto analgesico y anestesico local.
PH31258A (en) New use of ropivacaine.
HUT74290A (en) Process for the preparation of indolizine derivatives and the starting compound
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
SE9401596D0 (sv) New compounds
CA2189140A1 (en) New antagonist compounds
MX9605604A (es) Nuevos compuestos agonistas.
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
JO1658B1 (en) New vehicles
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis
NZ304823A (en) Beta carboline derivatives and medicaments